Below are the financial statements of West Pharmaceutical Services, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net sales | 2,893.2a | 2,949.8a | 2,886.9a |
| Cost of goods and services sold | -1,894.7a | -1,820.6a | -1,750.7a |
| Gross profit | 998.5a | 1,129.2a | 1,136.2a |
| Research and development | -69.1a | -68.4a | -58.5a |
| Selling, general and administrative expenses | -338.5a | -353.4a | -316.9a |
| Other expense (income) | 21a | 31.4a | 26.8a |
| Operating profit | 569.9a | 676a | 734a |
| Interest expense | -3a | -9a | -7.9a |
| Interest income | -19.6a | -28a | -5.1a |
| Other nonoperating expense (income) | 1a | -3a | 51.3a |
| Income before income taxes and equity in net income of affiliated companies | 585.5a | 698a | 679.9a |
| Income tax expense | -107.5a | -122.3a | -114.7a |
| Equity in net income of affiliated companies | -14.7a | -17.7a | -20.7a |
| Net income | 492.7a | 593.4a | 585.9a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore West Pharmaceutical Services’s data sources below and access millions more through our Disclosure Search.